Litcius/Paper detail

The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Cong Jiang, Shiyuan Zhang, Kun Qiao, Yuting Xiu, Yu Xiao, Yuanxi Huang

2022Clinical Breast Cancer15 citationsDOI

Topics & Concepts

MedicineNomogramBreast cancerInternal medicineStage (stratigraphy)Proportional hazards modelOncologyUnivariate analysisExact testCancerYouden's J statisticReceiver operating characteristicMultivariate analysisPaleontologyBiologyInflammatory Biomarkers in Disease PrognosisCancer Risks and FactorsCancer, Lipids, and Metabolism
The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | Litcius